Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Christina Orsmark Pietras"'
Autor:
Fatemah Rezayee, Jesper Eisfeldt, Aron Skaftason, Ingegerd Öfverholm, Shumaila Sayyab, Ann Christine Syvänen, Khurram Maqbool, Henrik Lilljebjörn, Bertil Johansson, Linda Olsson-Arvidsson, Christina Orsmark Pietras, Anna Staffas, Lars Palmqvist, Thoas Fioretos, Lucia Cavelier, Linda Fogelstrand, Jessica Nordlund, Valtteri Wirta, Richard Rosenquist, Gisela Barbany
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionThe suitability of whole-genome sequencing (WGS) as the sole method to detect clinically relevant genomic aberrations in B-cell acute lymphoblastic leukemia (ALL) was investigated with the aim of replacing current diagnostic methods.Metho
Externí odkaz:
https://doaj.org/article/40bdae45ba894ef6ae31e5164ee7f34f
Autor:
Carl Sandén, Henrik Lilljebjörn, Christina Orsmark Pietras, Rasmus Henningsson, Karim H. Saba, Niklas Landberg, Hanna Thorsson, Sofia von Palffy, Pablo Peña-Martinez, Carl Högberg, Marianne Rissler, David Gisselsson, Vladimir Lazarevic, Gunnar Juliusson, Helena Ågerstam, Thoas Fioretos
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Clonal evolution and heterogeneity has strong implications for treatment response in acute myeloid leukemia. Here, the authors use patient derived in vivo modelling to highlight the complex clonal and evolutionary dynamics underpinning acute myeloid
Externí odkaz:
https://doaj.org/article/e35f9025834f4b02be68bf3c32279eaa
Autor:
Susanne Bornelöv, Annika Sääf, Erik Melén, Anna Bergström, Behrooz Torabi Moghadam, Ville Pulkkinen, Nathalie Acevedo, Christina Orsmark Pietras, Markus Ege, Charlotte Braun-Fahrländer, Josef Riedler, Gert Doekes, Michael Kabesch, Marianne van Hage, Juha Kere, Annika Scheynius, Cilla Söderhäll, Göran Pershagen, Jan Komorowski
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80080 (2013)
Both genetic and environmental factors are important for the development of allergic diseases. However, a detailed understanding of how such factors act together is lacking. To elucidate the interplay between genetic and environmental factors in alle
Externí odkaz:
https://doaj.org/article/22c09e604aad4802b347c86b825c1071
Autor:
Nathalie Acevedo, Annika Sääf, Cilla Söderhäll, Erik Melén, Jami Mandelin, Christina Orsmark Pietras, Sini Ezer, Piia Karisola, Johanna Vendelin, Gustav Boije af Gennäs, Jari Yli-Kauhaluoma, Harri Alenius, Erika von Mutius, Gert Doekes, Charlotte Braun-Fahrländer, Josef Riedler, Marianne van Hage, Mauro D'Amato, Annika Scheynius, Göran Pershagen, Juha Kere, Ville Pulkkinen
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60111 (2013)
Retinoid acid receptor-related Orphan Receptor Alpha (RORA) was recently identified as a susceptibility gene for asthma in a genome-wide association study. To investigate the impact of RORA on asthma susceptibility, we performed a genetic association
Externí odkaz:
https://doaj.org/article/05e487baa79545f591a6284a69b73392
Autor:
Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martínez, Noelia Puente-Moncada, Carl Sandén, Anna M. Blom, Rasmus Henningsson, Gunnar Juliusson, Ben King, Niklas Landberg, Vladimir Lazarevic, Christina Orsmark-Pietras, Marianne Rissler, Vendela Rissler, Helena Ågerstam, Marcus Järås, Henrik Lilljebjörn, Thoas Fioretos
Publikováno v:
Blood Advances. 7:1204-1218
Mutated nucleophosmin 1 (NPM1) is the most common genetic alteration in acute myeloid leukemia (AML), found in ∼30% of cases. Although mutations in this gene are considered favorable according to current risk stratification guidelines, a large frac
Autor:
Åsa Rangert Derolf, Marianne Rissler, Petar Antunovic, Sören Lehmann, Lars Möllgård, Bertil Uggla, Henrik Lilljebjörn, Jörg Cammenga, Christina Orsmark-Pietras, Vladimir Lazarevic, Lovisa Wennström, Martin Höglund, Stefan Deneberg, Thoas Fioretos, Niklas Landberg, Fryderyk Lorenz
Publikováno v:
Genes, Chromosomes and Cancer. 60:426-433
Acute myeloid leukemia (AML) with t(9;22)(q34;q11), also known as AML with BCR-ABL1, is a rare, provisional entity in the WHO 2016 classification and is considered a high-risk disease according to the European LeukemiaNet 2017 risk stratification. We
Autor:
Hanna Thorsson, Rasmus Henningsson, Noelia Puente-Moncada, Carl Sandén, Signe Modvig, Marianne Rissler, Kajsa Paulsson, Anders Castor, Cornelis Jan Pronk, Hanne Vibeke Marquart, Kjeld Schmiegelow, Christina Orsmark-Pietras, Henrik Lilljebjörn, Thoas Fioretos
Publikováno v:
Blood. 140:3467-3468
Autor:
Eva, Berglund, Gisela, Barbany, Christina, Orsmark-Pietras, Linda, Fogelstrand, Jonas, Abrahamsson, Irina, Golovleva, Helene, Hallböök, Martin, Höglund, Vladimir, Lazarevic, Lars-Åke, Levin, Jessica, Nordlund, Ulrika, Norèn-Nyström, Josefine, Palle, Tharshini, Thangavelu, Lars, Palmqvist, Valtteri, Wirta, Lucia, Cavelier, Thoas, Fioretos, Richard, Rosenquist
Publikováno v:
Frontiers in medicine. 9
Whole-genome sequencing (WGS) and whole-transcriptome sequencing (WTS), with the ability to provide comprehensive genomic information, have become the focal point of research interest as novel techniques that can support precision diagnostics in rout
Autor:
Henrik Lilljebjörn, Felix Mitelman, Christina Orsmark-Pietras, Anna Hagström-Andersson, Thoas Fioretos
Publikováno v:
Seminars in cancer biology. 84
Transcriptional profiling of acute leukemia, specifically by RNA-sequencing or whole transcriptome sequencing (WTS), has provided fundamental insights into its underlying disease biology and allows unbiased detection of oncogenic gene fusions, as wel
Autor:
Christina, Orsmark-Pietras, Niklas, Landberg, Fryderyk, Lorenz, Bertil, Uggla, Martin, Höglund, Sören, Lehmann, Åsa, Derolf, Stefan, Deneberg, Petar, Antunovic, Jörg, Cammenga, Lars, Möllgård, Lovisa, Wennström, Henrik, Lilljebjörn, Marianne, Rissler, Thoas, Fioretos, Vladimir Lj, Lazarevic
Publikováno v:
Genes, chromosomescancerREFERENCES. 60(6)
Acute myeloid leukemia (AML) with t(9;22)(q34;q11), also known as AML with BCR-ABL1, is a rare, provisional entity in the WHO 2016 classification and is considered a high-risk disease according to the European LeukemiaNet 2017 risk stratification. We